These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2028453)

  • 21. Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).
    Sandset PM; Abildgaard U; Larsen ML
    Thromb Res; 1988 Jun; 50(6):803-13. PubMed ID: 3413731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Curr Stud Hematol Blood Transfus; 1991; (58):22-5. PubMed ID: 1954769
    [No Abstract]   [Full Text] [Related]  

  • 23. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition.
    Warn-Cramer BJ; Rao LV; Maki SL; Rapaport SI
    Thromb Haemost; 1988 Dec; 60(3):453-6. PubMed ID: 3238648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.
    Girard TJ; MacPhail LA; Likert KM; Novotny WF; Miletich JP; Broze GJ
    Science; 1990 Jun; 248(4961):1421-4. PubMed ID: 1972598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O; Valentin S; Beck TC; Hedner U
    Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction.
    Sandset PM; Warn-Cramer BJ; Maki SL; Rapaport SI
    Blood; 1991 Sep; 78(6):1496-502. PubMed ID: 1909195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas.
    Welsch DJ; Novotny WF; Wun TC
    Thromb Res; 1991 Oct; 64(2):213-22. PubMed ID: 1811340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism.
    Rapaport SI
    Blood; 1989 Feb; 73(2):359-65. PubMed ID: 2644974
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.
    Kopp CW; Siegel JB; Hancock WW; Anrather J; Winkler H; Geczy CL; Kaczmarek E; Bach FH; Robson SC
    Transplantation; 1997 Mar; 63(5):749-58. PubMed ID: 9075849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.
    Abildgaard U; Sandset PM; Andersson TR; Odegaard OR; Rosĕn S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):274-7. PubMed ID: 2465215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.
    Gemmell CH; Broze GJ; Turitto VT; Nemerson Y
    Blood; 1990 Dec; 76(11):2266-71. PubMed ID: 2257300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tissue factor region that interacts with factor Xa in the activation of factor VII.
    Kirchhofer D; Eigenbrot C; Lipari MT; Moran P; Peek M; Kelley RF
    Biochemistry; 2001 Jan; 40(3):675-82. PubMed ID: 11170384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue factor pathway inhibitor.
    Girard TJ; Broze GJ
    Methods Enzymol; 1993; 222():195-209. PubMed ID: 8412794
    [No Abstract]   [Full Text] [Related]  

  • 34. Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity.
    Dietzen DJ; Jack GG; Page KL; Tetzloff TA; Hall CL; Mast AE
    Thromb Haemost; 2003 Jan; 89(1):65-73. PubMed ID: 12540955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.
    Nakagaki T; Foster DC; Berkner KL; Kisiel W
    Biochemistry; 1991 Nov; 30(45):10819-24. PubMed ID: 1932002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease.
    Bajaj MS; Rana SV; Wysolmerski RB; Bajaj SP
    J Clin Invest; 1987 Jun; 79(6):1874-8. PubMed ID: 3034984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor VII and extrinsic pathway inhibitor in acute coronary disease.
    Sandset PM; Sirnes PA; Abildgaard U
    Br J Haematol; 1989 Jul; 72(3):391-6. PubMed ID: 2788454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease.
    Warr TA; Rao LV; Rapaport SI
    Blood; 1989 Aug; 74(3):994-8. PubMed ID: 2787683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human factor VIIa-tissue factor activity by placental anticoagulant protein.
    Kondo S; Noguchi M; Funakoshi T; Fujikawa K; Kisiel W
    Thromb Res; 1987 Nov; 48(4):449-59. PubMed ID: 2965430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
    Rapaport SI
    Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.